Cargill has confirmed it is in “exclusive discussions” to sell global cultures and enzymes business to Dutch ingredients giant DSM.
The US-based agricultural commodities group said the talks “may or may not” result in the sale of the cultures and enzymes operation which forms part of its global texturising business and has production facilities in Wisconsin and La Ferte-Sous-Jouarre (France). It produces cultures and enzymes for the dairy and meat industries and employs around 200 people.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Cargill said “both companies are now engaging in the information and consultation process with employee representative bodies in the relevant countries to seek their input”.
Cargill’s move to seek a buyer for the business is in line with its strategy to focus its texturising business on product lines that are closer to its core activities and where it can be a “leading or relevant player in the marketplace”.
